Delivery Order SPE2DB22D3011-SPE2DB24FP9YN

Award Date 3/18/24
Potential Completion Date 3/19/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Spiriva Respimat 2.5 MCG INH 4GM medication to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $36,215.85, has a performance period ending on March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and the contract does not have a set-aside designation. This delivery order is part of a larger...
This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) for the provision of Spiriva Respimat 2.5 mcg inhalation medication. The contract has a potential value of $1,035.01 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designation. The company also...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,926.08 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of Spiriva Respimat 2.5 mcg inhalation medication in support of military treatment programs and facilities. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp...
This is a federal delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,360.56 firm fixed-price contract is for the supply of Spiriva Respimat 1.25 mcg inhalation medication. The award has an ultimate completion date of July 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,602.25, is for the provision of Spiriva Respimat 2.5 mcg inhalation medication. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Spiriva Respimat 2.5 MCG INH 4GM. The $1,533.26 fixed-price contract has an ultimate completion date of April 29, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $8,352.89 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Spiriva Respimat 2.5 mcg inhalation medication. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp that has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC serves as the primary contract vehicle...
This federal contract award, valued at $1,020.06, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Spiriva Respimat 1.25 MCG INH 4GM, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a period of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,380.79 contract is for the supply of Spiriva Respimat 1.25 mcg inhalers. It is a firm-fixed-price, delivery order contract with a completion date of May 21, 2024. Amerisourcebergen is a major pharmaceutical distributor that supports the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare...
This federal contract award is a delivery order with a firm fixed price valued at $1,570.08 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order is for the supply of 4,564,071,804 units of the inhalation medication Spiriva Respimat 1.25 mcg. The contract does not have a set-aside designation and has an ultimate completion date of March 26, 2024. Amerisourcebergen Drug Corp holds...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FP9YN
    Delivery Order

This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,050.98 contract is for the supply of Spiriva Respimat 2.5 mcg inhalation medication, with a completion date of March 19, 2024.

Amerisourcebergen Drug Corp is the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical that serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to military treatment facilities worldwide. The IDC does not have any set-aside designations and was awarded solely to Amerisourcebergen Drug Corp.

Generated 6/17/24, 9:09 AM